Nutra Pharma Corp banner

Nutra Pharma Corp
OTC:NPHC

Watchlist Manager
Nutra Pharma Corp Logo
Nutra Pharma Corp
OTC:NPHC
Watchlist
Price: 0.0003 USD Market Closed
Market Cap: $2.1m

Wall St Price Targets

NPHC Price Targets Summary
Nutra Pharma Corp

There are no price targets for NPHC.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Nutra Pharma Corp Competitors:
Price Targets
NYXH
Nyxoah SA
221% Upside
KRNY
Kearny Financial Corp
7% Upside
CASY
Caseys General Stores Inc
-12% Downside
SANA
Sana Biotechnology Inc
150% Upside

Revenue
Forecast

7% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 9 years is 8%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NPHC's stock price target?
Not Available

NPHC does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Nutra Pharma Corp?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 9 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett